产品介绍 |
AZD2858是GSK-3抑制剂,能激活Wnt信号通路。 |
备注 |
AZD2858 is a selective GSK-3 inhibitor with an IC50 of 68 nM, activating Wnt signaling, increases bone mass in rats. |
生化机理 |
AZD2858 is a selective GSK-3 inhibitor with an IC50 of 68 nM, inhibits tau phosphorylation at the S396 site, activates Wnt signaling pathway. AZD2858 treatment (1 μM, 12 h) on primary isolated human osteoblast-like cells results in a 3-fold increase of β-catenin levels. AZD2858 causes β-catenin stabilisation in human and rat mesenchymal stem cells, stimulates hADSC commitment towards osteoblasts and osteogenic mineralisation in vitro |
别名 |
3-氨基-6-(4-((4-甲基-1-哌嗪基)磺酰基)苯基)-N-3-吡啶基-吡嗪甲酰胺;;AZD 2858;AZD-2858;3-amino-6-(4-((4-methyl-1-piperazinyl)sulfonyl)phenyl)-n-3-pyridinyl-pyrazinecarboxamide |